tiprankstipranks
Kaleido Biosciences Inc (KLDO)
OTHER OTC:KLDO
US Market

Kaleido Biosciences (KLDO) Financial Statements

195 Followers

Kaleido Biosciences Financial Overview

Kaleido Biosciences's market cap is currently ―. The company's EPS TTM is $; its P/E ratio is ―; Kaleido Biosciences is scheduled to report earnings on November 7, 2022, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 21Sep 21Jun 21Mar 21Dec 20
Income Statement-
Total Revenue$ 488.00K$ 104.00K$ 211.00K$ 297.00K$ 243.00K
Gross Profit$ 488.00K$ 104.00K---
EBIT$ -19.85M$ -22.38M$ -23.18M$ -22.33M$ -19.30M
EBITDA$ -19.07M$ -21.61M$ -22.60M$ -21.76M$ -18.73M
Net Income Common Stockholders$ -20.57M$ -23.09M$ -23.89M$ -23.04M$ -20.02M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 38.50M$ 55.66M$ 71.98M$ 92.36M$ 46.22M
Total Assets$ 50.16M$ 67.80M$ 84.29M$ 105.03M$ 59.34M
Total Debt$ 21.69M$ 21.52M$ 21.34M$ 21.19M$ 21.01M
Net Debt$ -16.81M$ -34.14M$ -50.63M$ -71.17M$ -25.21M
Total Liabilities$ 39.53M$ 38.60M$ 34.02M$ 33.25M$ 38.85M
Stockholders Equity$ 10.61M$ 29.20M$ 50.27M$ 71.77M$ 20.50M
Cash Flow-
Free Cash Flow$ -17.17M$ -16.31M$ -20.32M$ -24.00M$ -11.96M
Operating Cash Flow$ -17.17M$ -15.88M$ -20.08M$ -23.97M$ -11.30M
Investing Cash Flow$ 2.00K$ -431.00K$ -232.00K$ -30.00K$ -662.00K
Financing Cash Flow$ -25.00K$ -14.00K$ -68.00K$ 70.14M$ 3.65M
Currency in USD

Kaleido Biosciences Earnings and Revenue History

Kaleido Biosciences Debt to Assets

Kaleido Biosciences Cash Flow

Kaleido Biosciences Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis